central and peripheral glp 1 systems independently suppress eating Glucagon-like Peptide-1 the Central/Peripheral Nervous System: Crosstalk in Diabetes: Trends in Endocrinology & Metabolism Mechanisms of GLP-1 Receptor Agonist-Induced

OxLDL components and their interaction with toll-like receptors (TLRs) 2 and 4, CD36 and other cellular receptors further mediate thromboinflammation enhancing tissue and organ damage culminating in organ failure, i.e., myocardial infarction, stroke, and pulmonary artery embolism (174, 209212)

Do not stop a prescribed medication or change the dose without discussing it with the prescribing provider, particularly when the treatment affects hormones, blood sugar, appetite, or cardiovascular function

doi: 10.1371/journal.pone.0193114 18 Gawrys-KopczynskaM.KonopM.MaksymiukK.KraszewskaK.DerzsiL.SozanskiK.et al

Antioxidants 13, 1508